DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1404
VULINACIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
VULINACIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
SA09JNQ24D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIPASETAMAB
1
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
MIPASETAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OTLERTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
OTLERTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
2MZ3L2664T
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CM-101
1
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
CM-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFASEVIKUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin 17A inhibitor
AFASEVIKUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
TG8A3DSU6Z
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIMURUTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
Unknown
PIMURUTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5V1Y8T4RB6
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LMB-7
1
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Lewis Y antigen binding agent
LMB-7
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TNX-100
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
TNX-100
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TELISOTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
TELISOTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
R15ZW356HN
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LBY-135
1
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 10B agonist
LBY-135
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ONGERICIMAB
1
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia; Hyperlipidemias
Unknown
ONGERICIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
X126G5DZ36
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMERFETAMAB
1
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
EMERFETAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUMILIXIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin epsilon Fc receptor antagonist
LUMILIXIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
8Z13S29R5A
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEMZOPARLIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma
Unknown
LEMZOPARLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENAVATUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 12A agonist
ENAVATUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
914910XFBB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FP-1305
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
FP-1305
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN 111 ALTUMOMAB PENTETATE
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
INDIUM IN 111 ALTUMOMAB PENTETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAXDILIMAB
1
Antibody
Investigational
Unknown
Unknown
Acute Lung Injury; Lupus Erythematosus, Systemic
Unknown
DAXDILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
CNI3N6QR71
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORILANOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Anemia, Hemolytic, Autoimmune
Unknown
ORILANOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1LTT6HMX9N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVIZAKIMAB
1
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Unknown
AVIZAKIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4H3BBE5WVK
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-2338
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Pulmonary Disease, Chronic Obstructive; Still's Disease, Adult-Onset
Interleukin-18 cross-linking agent
MEDI-2338
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MLN-591RL
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MLN-591RL
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-936564
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-936564
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLANVOTUMAB
1
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
FLANVOTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
ZNV4738BS6
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AD-439
1
Antibody
Investigational
Unknown
Unknown
Unknown
Envelope polyprotein GP160 inhibitor
AD-439
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PETOSEMTAMAB
1
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
PETOSEMTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SC-1
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
SC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MFGR1877S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MFGR1877S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDEC-159 111IN
1
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Tumor-associated antigen 72 binding agent
IDEC-159 111IN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MU-J591
1
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
MU-J591
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEBOTELIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Hepatocellular; Endometrial Neoplasms; Stomach Neoplasms; Carcinoma, Squamous Cell
Lymphocyte activation gene 3 protein inhibitor
TEBOTELIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
L62556GPXB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PG-110
1
Antibody
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Beta-nerve growth factor inhibitor
PG-110
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
10
11
12
13
14
15
16
…
40
41
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA